Back to News
Market Impact: 0.55

Crocs stock price target lowered to $99 by BofA on weak guidance

JPMCROXBCS
Company FundamentalsCorporate EarningsCorporate Guidance & OutlookAnalyst InsightsConsumer Demand & RetailTax & TariffsInvestor Sentiment & Positioning
Crocs stock price target lowered to $99 by BofA on weak guidance

Crocs (NASDAQ:CROX) has faced multiple analyst downgrades and price target reductions, including BofA Securities lowering its target to $99 from $135 and Barclays to $81 from $119, following disappointing Q3 guidance despite strong Q2 2025 results that exceeded expectations. While BofA maintains a Buy rating, citing robust margins and international growth, other firms like Williams Trading and Barclays have downgraded the stock due to macroeconomic uncertainty and challenges with the HEYDUDE brand. This mixed outlook has led to a significant stock decline of over 23% in the past week, reflecting investor apprehension regarding the company's near-term growth trajectory.

Analysis

Crocs (CROX) is currently facing a significant disconnect between its recent financial performance and its forward-looking guidance, creating a polarized view among analysts. The company delivered strong second-quarter 2025 results, with adjusted EPS of $4.23 and revenue of $1.15 billion, both surpassing consensus forecasts. Operationally, the company demonstrates robust health, evidenced by impressive gross profit margins of 59.25%, a record-level Crocs brand gross margin of 64.2%, and a strong free cash flow yield of 22%. Furthermore, its international segment, constituting half of total sales, grew 16% in Q2. Despite these strengths, the stock has plummeted over 23% in one week, a direct reaction to what analysts termed "disappointing" third-quarter guidance that fell significantly short of expectations. This weak outlook prompted several downgrades, including from Williams Trading (to Hold) and Barclays (to Equalweight), which cited macroeconomic uncertainty, challenges with the HEYDUDE brand, and a U.S. consumer shift toward athletic footwear. While BofA Securities cut its price target to $99.00, it maintained a Buy rating, arguing that the risk/reward is favorable and fundamental improvements are likely beyond Q3, highlighting a clear division in market sentiment.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.